TrialPloS one2016

Identification of IGFBP2 and IGFBP3 As Compensatory Biomarkers for CA19-9 in Early-Stage Pancreatic Cancer Using a Combination of Antibody-Based and LC-MS/MS-Based Proteomics.

Toshihiro Yoneyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.